Does RUXOLITINIB Cause Febrile neutropenia? 697 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 697 reports of Febrile neutropenia have been filed in association with RUXOLITINIB (OPZELURA). This represents 1.0% of all adverse event reports for RUXOLITINIB.
697
Reports of Febrile neutropenia with RUXOLITINIB
1.0%
of all RUXOLITINIB reports
55
Deaths
652
Hospitalizations
How Dangerous Is Febrile neutropenia From RUXOLITINIB?
Of the 697 reports, 55 (7.9%) resulted in death, 652 (93.5%) required hospitalization, and 115 (16.5%) were considered life-threatening.
Is Febrile neutropenia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 697 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Febrile neutropenia?
CYCLOPHOSPHAMIDE (11,318)
DOXORUBICIN (8,844)
VINCRISTINE (8,676)
RITUXIMAB (6,382)
CYTARABINE (6,142)
METHOTREXATE (6,091)
ETOPOSIDE (5,966)
CARBOPLATIN (4,888)
DEXAMETHASONE (4,382)
PREDNISONE (3,956)
Which RUXOLITINIB Alternatives Have Lower Febrile neutropenia Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE